Search Results
Results found for "GPCR Biology"
- AELIS PHARMA launches their IPO for €25 million
innovation #traitements #addiction #cannabis #Trisomie21 #Downsyndrome" Read more at the source #DrGPCR #GPCR
- Disentangling bias between G q, GRK2, and arrestin3 recruitment to the M 3 muscarinic acetylcholine
G protein-coupled receptors (GPCRs) transmit extracellular signals to the inside by activation of intracellular
- Pharmacology at Your Fingertips: Terry’s Corner Launches
Yamina’s Corner delivers GPCR consulting that cuts through the noise, designing assay cascades, setting With a biology-first strategy, embedded execution, and scalable systems, it turns scattered data into Read The Full Article GPCR Publication Highlights Chemokine–GPCR Selectivity Unveiled Sequence- and Distinct Ligand Activation in NMBR Simulations show how two ligands differently activate class A GPCR GPCR Team Join Our Newsletter!
- Profiling Immune Cell and Platelet Transcriptomes
G protein-coupled receptors (GPCRs) are integral to cellular signaling, influencing a wide array of physiological advancements in transcriptomic profiling have provided new insights into the expression patterns of GPCRs The study reports that human white blood cells express an average of 160 GPCR mRNAs, ranging from 123 to 206, while platelets exhibit a distinct profile with 69 GPCR mRNAs. abundant and rare GPCR transcripts.
- APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
Significant advancements in the cellular biology of G protein-coupled receptors (GPCRs) about a novel This study, published in Nature Chemical Biology, highlights the role of the chaperone protein DNAJC13 fluorescence serves as a readout for the activity of APEX2 and, by extension, the trafficking of the GPCR The implications of this research extend beyond basic science ; understanding the role of DNAJC13 in GPCR field continues to evolve, this study represents a crucial step toward unraveling the understanding of GPCR
- Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks
GPCR tools and key moves in the biotech world. Dr. GPCR Updates We want your feedback - Help shape the future of Dr. GPCR. Your voice matters. GPCR Ambassador - Share & refer with Dr. GPCR. Help grow the GPCR community by joining the Dr. GPCR affiliate program. GPCR Team
- When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission
“So I had to understand the biology myself.” researchers needs to start from lived experience, not just literature. _________________ Keyword Cloud: GPCR research community , chronic pain , GPCR drug discovery , GPCR scientist network , pain neuroscience
- Mapping Motion: Intermediate States, Deorphanization & Discovery
GPCR Colleagues & Curiosity-Driven Minds, We’re starting with exciting Dr. GPCR Symposia – On-demand talks from GPCR trailblazers Watch anytime. Learn from the best. Explore the Symposia GPCR Publication Highlights Arrestin recognizes GPCRs independently of the receptor G(z)ESTY as an optimized cell-based assay for initial steps in GPCR deorphanization . GPCR Team
- Lab Leadership Without Ego: How Sokhom Pin Built the Happiest Team at Alkermes
At Alkermes , Sokhom Pin wasn’t just leading GPCR programs; he was building culture from the ground up In a field like GPCR research (where data complexity and failure rates are high), scientific rigor thrives GPCR ecosystem , GPCR research community , GPCR podcast , GPCR data platform , GPCR training program
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
GPCR ecosystem members! GPCR ecosystem. few years ago by some former colleagues and their description of the company was very intriguing: a biology Top candidates will have a solid foundation in GPCR pharmacology as well as some experience in drug discovery GPCR
- Signals in Motion: Pain, Metabolism & Terry’s Corner
Hello GPCR Innovators , We’re preparing to launch Terry’s Corner, a new knowledge hub shaped by Dr. Terry Kenakin’s decades of GPCR insight. delivers selective pain relief in preclinical models Dr.GPCR Updates Terry’s Corner – Build Better GPCR Stay curious, stay connected, because the future of GPCR science is being written pathway by pathway. GPCR Team
- Exclusive Access: Terry's Corner is LIVE + Your Premium Member Discount!
GPCR Ecosystem Member, you've been with us as we've laid the groundwork for something truly special. GPCR Ecosystem, we're giving Dr. GPCR Premium Members a significantly reduced access to Terry's Corner for a limited time. GPCR Team & Terry’s Desk
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
Watch Episode 172 The Bigger Picture: GPCR Science Meets Public Health At its core, Catherine Demery’ For scientists, this means rethinking how we study GPCR-mediated respiratory depression. Why This Research Matters Beyond the Lab Catherine’s findings bridge the gap between basic receptor biology In other words, this is GPCR science with immediate, life-or-death consequences. They’re rewriting the biology of overdose.
- From Technician to Trailblazer: How Sokhom Pin Designed His Own PhD Program While Working in Industry
. _________________ Keyword Cloud: GPCR training program , GPCR scientist network , GPCR drug discovery , G protein-coupled receptors , GPCR online course
- Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of ...
Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4 WHIM syndrome is a rare immunodeficiency disorder that is characterized by warts, hypogammaglobulinemia, infections, and myelokathexis. While several gain-of-function mutations that lead to C-terminal truncations, frame shifts and point mutations in the chemokine receptor CXCR4 have been identified in WHIM syndrome patients, the functional effect of these mutations are not fully understood. Here, we report on a new WHIM syndrome mutation that results in a frame shift within the codon for Ser339 (S339fs5) and compare the properties of S339fs5 with wild type CXCR4 and a previously identified WHIM syndrome mutant, R334X. The S339fs5 and R334X mutants exhibited significantly increased signaling compared to wild type CXCR4 including agonist-promoted calcium flux and extracellular signal-regulated kinase activation. This increase is at least partially due to a significant decrease in agonist-promoted phosphorylation, β-arrestin binding, and endocytosis of S339fs5 and R334X compared to wild type CXCR4. Interestingly, there were also significant differences in receptor degradation, with S339fs5 having a very high basal level of degradation compared to that of R334X and wild type CXCR4. In contrast to wild type CXCR4, both R334X and S339fs5 were largely insensitive to CXCL12-promoted degradation. Moreover, while basal and agonist-promoted degradation of wild type CXCR4 was effectively inhibited by the CXCR4 antagonist TE-14016, this had no effect on the degradation of the WHIM mutants. Taken together, these studies identify a new WHIM syndrome mutant, CXCR4-S339fs5, that promotes enhanced signaling, reduced phosphorylation, β-arrestin binding and endocytosis, and a very high basal rate of degradation that is not protected by antagonist treatment. Read full article
- Building Backwards: Why Top-Down Models Could Revolutionize Pain Research
This allows him to see how inflammation, cognition, and pain circuits overlap , and how GPCRs might serve And it challenges the GPCR community to use its tools not just to explain, but to intervene. the case for building pain research from the clinic down, not the bench up. ________ Keyword Cloud: GPCR podcast , pain modeling , GPCR online course , translational research , neuroimmune signaling .
- Coordinated transcriptomics and peptidomics of central nervous system identify neuropeptides and ...
Neuropeptides and their specific receptors (primarily G protein-coupled receptors, GPCRs) regulate multiple biological functions in insects and represent promising next-generation pest management strategy. A total of 41 neuropeptide GPCR genes belonging to three classes were also identified. These GPCRs and their probable ligands were predicted. to determine physiological functions and pharmacological characterization of neuropeptides and their GPCRs
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
There were several sections, among them one specific for GPCRs. Sometimes when you’re in the field you forget the importance GPCRs holds in drug development as a whole Session 4 on Wednesday was dedicated to GPCRs. The talks given targeted both traditional GPCRs such as the serotoninergic receptor 5HT1A, but also newer
- Knowing When to Walk, Knowing When to Run: Lessons from the Bench
. _________________ Keyword Cloud: GPCR online course, early-career scientists, imposter syndrome, GPCR podcast, neuroma model
- Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and ...
Information exchange and interpretation is essential in biology and understanding how cells integrate information-coding molecules into complex orchestrated responses is a major challenge for modern cell biology The G protein-coupled receptors (GPCRs) are the largest family of membrane receptors, with nearly 800 The recognition that GPCRs may physically interact with each other has led to the hypothesis that their new ideas about the physiological role played by receptor homo- and hetero-oligomerization in cell biology
- Science Needs Rigor, But Also Joy
. _________________ Keyword Cloud: GPCR scientist network, GPCR training program, mentorship in science
- Do You Believe AI Could Accelerate Drug Discovery?
G protein-coupled receptors (GPCRs) are major drug targets, yet their complex and dynamic structures By using machine learning, AF2 can accurately predict the 3D structures of GPCRs with atomic-level accuracy The AlphaFold database encompasses over 200 million proteins, aiding structural biology, protein design Furthermore, AI's role in structural biology and drug design is set to spark innovation in automated
- Phospholipid Scrambling by G Protein-Coupled Receptors
Rapid flip-flop of phospholipids across the two leaflets of biological membranes is crucial for many Unexpectedly, Class A G protein-coupled receptors (GPCRs), a large class of signaling proteins exemplified transbilayer lipid movement, conceptualized as the swiping of a credit card (lipid) through a card reader (GPCR Conformational changes that facilitate scrambling are distinct from those associated with GPCR signaling In this review, we discuss the physiological significance of GPCR scramblase activity and the modes of
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
When a compound’s off-rate is slower than its clearance, its biological effect outlives its plasma presence Dosing regimens aligned with biology, not just exposure. GPCR members save 50%+ with your Weekly News code. 👉 Join Terry’s Corner & Secure Your Spot for the Kenakin with your own enzyme or GPCR interaction puzzles.
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
different ligands acting on the same receptor trigger distinct signaling pathways, leading to varied biological significant attention in drug discovery, especially in the context of G protein-coupled receptors (GPCRs The GLP-1R, a class B1 GPCR, is integral to metabolic regulation, particularly in glucose homeostasis Cary, B.P., et al., New Insights into the Structure and Function of Class B1 GPCRs.
- Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin ...
Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin Interaction G protein-coupled receptors (GPCRs The β2-adrenergic receptor (β2AR) is a prototypical and extensively studied GPCR that can provide insight into this aspect of GPCR signaling thanks to robust structural data and rich pharmacopeia. regulation that may contribute to biased signaling at GPCRs. We characterized the effects of extracellular loop mutations on agonist-promoted interactions of GPCRs
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
bilayer creates is dynamic and interactive, becoming the foundation for many interactions involved in GPCR activation of GPCRs2. β-arrestins are cytosolic proteins that translocate to the plasma membrane upon GPCR Understanding the interplay between GPCRs and β-arrestins and how this complex operates on the plasma Membrane phosphoinositides regulate GPCR-β-arrestin complex assembly and dynamics. Molecular mechanism of GPCR-mediated arrestin activation.
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
resulting phenotype, researchers can identify essential domains and residues crucial for the protein's biological residues spans from the extracellular surface to the transmembrane area, linking with canonical class A GPCR activation motifs to initiate proton-sensing GPCRs. directions will likely focus on enhancing its scalability, accuracy, and applicability across broader biological Another promising development is the application of DMS to a wider array of biological systems, including
- The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of ...
all cytomegalovirus (CMV) genomes analysed to date is the presence of G protein-coupled receptors (GPCR IMPORTANCE G protein-coupled receptors (GPCRs) act as cell surface molecular "switches" which regulate All cytomegalovirus (CMV) genomes analysed to date possess GPCR homologs with phylogenetic evidence for The mouse CMV (MCMV) GPCR homolog, designated M33, is important for cell-associated virus spread and The signalling repertoire of M33 is distinct from cellular GPCRs and little is known of the relevance
- TLR4 biased small molecule modulators
Currently, attention was mainly paid to biased signaling modulators targeting G protein-coupled receptors (GPCRs The biased signaling modulation of non-GPCR receptors has yet to be exploited. Toll-like receptor 4 (TLR4) is one such non-GPCR receptor, which involves MyD88-dependent and TRIF-dependent modulators of TLR4 would provide insight for the future development of biased modulators for other non-GPCR
















